The healthcare industry has been evolving with new regulations and aging customers. Companies need to add services, expand their customer bases and find new markets for growth, all while reducing costs. Specialty pharmacy is one area in which providers are seeking targets. Strategic buyers have been actively pursuing deals in the space, particularly in oncology and rheumatology.
McKesson Corp. executive vice president of corporate strategy and business development Bansi Nagji tells Mergers & Acquisitions that the company is currently focusing on expanding in oncology and has deals in the space, including the purchase of oncology pharmacy provider Biologics.